Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Ann Surg Oncol. 2013 Dec 12;21(4):1202–1208. doi: 10.1245/s10434-013-3408-5

Table 1.

Baseline patient and surgical characteristics of subjects (n =144).

n=144

Age, mean (range) 59 (36–85)

BMI, mean (range) 29 (17–48)

BMI category, n (%)
 <25 32 (22.2)
 25–29 58 (40.3)
 30–34 27 (18.8)
 ≥35 27 (18.8)

Current smoker, n (%) 7 (4.9)

Bra cup size, n (%)
 A 9 (6.3)
 B 43 (30.1)
 C 60 (42.0)
 D 22 (15.4)
 >D 9 (6.3)

Recent prior biopsy

 None 6 (4.2)
 Needle 130 (90.3)
 Surgical 8 (5.6)

Operation, n (%)

 Excisional biopsy only 32 (22.2)
 WLE only 14 (9.7)
 WLE+SLNB 79 (54.9)
 WLE+ALND 19 (13.2)

Location scar, n (%)

 UOQ 74 (51.4)
 LOQ 16 (11.1)
 LIQ 11 (7.6)
 UIQ 11 (7.6)
 Central 32 (22.2)

Number of nodes removed*, median (range) 3 (1–38)

Tumor stage**, n (%)
 Tis 25 (22.3)
 T1 72 (64.3)
 T2 14 (12.5)
 T3 1 (0.9)

Tumor size*** (cm), median (range) 1.3 (0.02–8.4)

Node stage***, n (%)
 N0 61 (70.1)
 N1 18 (20.7)
 N2 4 (4.6)
 N3 4 (4.6)
*

Including only those with an axillary procedure (n=98).

**

Including only those with cancer (n=112).

***

Including only those with invasive cancer (T1-T3) (n=87).